Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lori Leslie
Comparative Analysis of Targeted Novel Therapies in Relapsed, Refractory Chronic Lymphocytic Leukaemia
Haematologica
Hematology
Related publications
Cost-Effectiveness of Ibrutinib in Patients With Relapsed or Refractory (RR) Chronic Lymphocytic Leukaemia (CLL) in England
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Analysis of Treatment Options for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Chromosomal Imbalances in Familial Chronic Lymphocytic Leukaemia: A Comparative Genomic Hybridisation Analysis
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Chronic Lymphocytic Leukaemia
Nature Reviews Disease Primers
Medicine
Psy63 - Cost by Outcomes Analysis of Novel Triple-Combination Therapies for Relapsed/Refractory Multiple Myeloma in Brazil
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Utility of Idelalisib in Combination With Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)
Current Hematologic Malignancy Reports
Cancer Research
Oncology
Hematology
Comparison of Innate Immunity Changes Following Ibrutinib and Venetoclax Treatment of Relapsed Chronic Lymphocytic Leukaemia
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Phase 2 Study of Acalabrutinib in Ibrutinib-Intolerant Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology